Aloe vera Aloe vera (also listed as Aloe barbadensis)
Also called: aloe, aloe gel, aloe latex
A cactus-like plant of hot, dry climates. Products use three different parts of the leaf: the clear inner-leaf gel (mostly on the skin), the yellow outer-leaf latex (historically a laxative), and the whole crushed leaf.
- Category
- Botanical
- Part used
- Leaf: inner-leaf gel, outer-leaf latex, or whole crushed leaf
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2022 systematic review (Front Pharmacol) pooled 14 RCTs (1,572 participants) of aloe vera applied to the skin (fresh leaf, gel, cream or lotion) during radiotherapy; the review did not state cream and lotion compositions. This count covers topical use only. [6]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CBlood sugar and weight2 topics
CSkin and hair2 topics
CSeveral areas, whole body or blood1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Burns (gel applied to the skin) | C | NCCIH reports that clinical research suggests topical aloe gel may shorten burn recovery and reduce burn pain; the summary gives no trial sizes or designs. [1] |
| Acne (gel on the skin, alongside other treatments) | C | Two small studies suggest topical aloe gel used together with other treatments may improve acne. [1] |
| Blood sugar in people with diabetes (oral) | C | Small studies suggest oral aloe may lower fasting blood sugar and HbA1c in people with diabetes. [1] |
| Body weight in adults with overweight or obesity and diabetes or prediabetes | C | One small study found a specific oral gel product taken for 8 weeks modestly reduced body weight and fat mass. [1] |
| Eczema, diabetic foot ulcers, irritable bowel syndrome, ulcerative colitis | C | NCCIH states that reliable information is lacking on whether aloe helps these conditions. [1] |
Main constituents: Acemannan (a carbohydrate fraction), emodin and aloeride are named as constituents [2]; Anthraquinones are present in aloe juice and latex, not in the clear gel [2]; Aloin is the marker used to set limits for drinkable products (see Quality) [1]
Safety and side effects
- Liver (NIH LiverTox)Score BABCDEA: well known causeE: unlikely cause
LiverTox likelihood score B: likely but rare cause of clinically apparent liver injury (chapter last updated May 24, 2022).
Details and sources - Pregnancy and breastfeedingEU monograph on dried aloe leaf juice: use during pregnancy is contraindicated because of experimental data on a genotoxic risk of several …
4 statements in the profile.
Details and sources - Interactions with medicines5 listed
Cardiac glycosides and antiarrhythmic medicines; Diuretics and adrenal corticosteroids; Digoxin; Drugs metabolized by CYP3A4 or CYP2D6 …
Details and sources - Cancer evaluations (IARC, NTP)3 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notifications1 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographs3 statements
EU herbal monograph, well-established use (EMA/HMPC/625788/2015, adopted 22 November 2016): dried aloe leaf juice preparation equivalent to 10-30 mg …
Details and sources
- Topical gel is generally well tolerated; occasional burning, itching, rash and eczema have been reported. [1]
- Studies suggest oral aloe gel is safe for short-term use of up to 42 days. Oral latex can cause abdominal pain, cramps and diarrhea. [1]
- Oral aloe leaf extracts taken for 3 weeks to 5 years have been linked to cases of acute hepatitis. [1]
- In 2-year drinking-water studies, a nondecolorized whole-leaf extract showed clear evidence of carcinogenic activity in male and female rats (adenomas and carcinomas of the large intestine) and no evidence in mice. [3]
- IARC classified non-decolorized whole-leaf extract as a possible human carcinogen. Limited lab research suggests even decolorized extract could damage DNA or chromosomes. [1]
- Case reports with oral aloe supplements include low blood potassium (during chemotherapy), thyroid dysfunction, and toxic hepatitis after several months of use. [2]
- Pregnancy and breastfeeding: oral aloe in any form may be unsafe; consult a health care provider. [1]
Interactions
| With | What happens |
|---|---|
| Digoxin and other cardiac glycosides | Overusing aloe latex may increase the risk of side effects from cardiac glycosides such as digoxin. [1] |
| Drugs metabolized by CYP3A4 or CYP2D6 | Aloe juice inhibited CYP3A4 and CYP2D6 and may affect concentrations of drugs metabolized by these enzymes; clinical relevance is not known. [2] |
| Sevoflurane (anesthetic) | Excessive bleeding during surgery was reported in a patient after oral use of aloe vera tablets. [2] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Gel, juice and latex are different materials: juice and latex contain anthraquinones, and gel should not be confused with them. [2]
- A 2023 review found that food-grade drinkable aloe products containing no more than 10 ppm aloin were not genotoxic. [1]
- Most animal safety testing used non-decolorized leaf extract, a form consumers rarely use. [1]
Regulatory status
- US: FDA final rule (May 9, 2002; effective November 5, 2002) found aloe (including aloe extract and aloe flower extract) and cascara sagrada not generally recognized as safe and effective for OTC laxative use, citing absent data, including requested carcinogenicity data (21 CFR 310.545). [4]
- US: oral aloe products are often sold as dietary supplements, which FDA does not approve before sale. [1]
- EU: dried aloe leaf juice has a European Union herbal monograph based on well-established use for short-term relief of occasional constipation, in adults and adolescents over 12, for no longer than 1 week. [5]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Anthraquinones, among more than 75 identified substances in aloe vera products Anthraquinones (phenolic compounds with laxative actions) [P6]
- Aloinosides, aloins and hydroxyaloins (in dried leaf juice; doses expressed as hydroxyanthracene derivatives calculated as aloin) Hydroxyanthracene derivatives (anthranoids) [P7]
- Acemannan, a carbohydrate fraction named as a constituent Polysaccharide [P2]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 1 entry naming Aloe vera (NDI 995, 'Aloe vera extract', submitted 2017-02-22). Other entries name different Aloe species (Aloe arborescens, Aloe macroclada). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P10]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- IARC: Aloe vera, whole leaf extract, Group 2B (possibly carcinogenic to humans), IARC Monographs Volume 108 (2016). The classification names whole leaf extract, not the clear inner-leaf gel. [P5]
- NTP TR-577 (2013), nondecolorized whole leaf extract of Aloe vera in drinking water for 2 years: clear evidence of carcinogenic activity in male and female F344/N rats (adenomas and carcinomas of the large intestine); no evidence of carcinogenic activity in male or female B6C3F1 mice. [P3]
- NTP TR-553 (2010), creams containing aloe gel, whole leaf or decolorized whole leaf extract, or aloe-emodin applied with simulated solar light to SKH-1 hairless mice: a weak enhancing effect on the photocarcinogenic activity of the light (aloe gel or aloe-emodin in females only; whole leaf or decolorized whole leaf in both sexes). [P4]
Liver (NIH LiverTox)
- LiverTox likelihood score B: likely but rare cause of clinically apparent liver injury (chapter last updated May 24, 2022). [P6]
Interactions with medicines
- Cardiac glycosides and antiarrhythmic medicines: EU monograph on dried aloe leaf juice: low blood potassium resulting from long-term laxative abuse potentiates the action of cardiac glycosides and interacts with antiarrhythmic medicinal products. [P7]
- Diuretics and adrenal corticosteroids: EU monograph on dried aloe leaf juice: concomitant use may enhance loss of potassium. [P7]
- Digoxin: NCCIH: overusing aloe latex may increase the risk of side effects from cardiac glycosides such as digoxin. [P1]
- Drugs metabolized by CYP3A4 or CYP2D6: Aloe juice inhibited CYP3A4 and CYP2D6 and may affect concentrations of drugs metabolized by these enzymes; clinical relevance is not known. [P2]
- Sevoflurane (anesthetic): Excessive bleeding during surgery was reported in a patient after oral use of aloe vera tablets. [P2]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- Licorice root: EU monograph on dried aloe leaf juice: concomitant use with licorice root may enhance loss of potassium. [P7]
Adulteration and substitution
- A 2016 J AOAC International paper cites continuing adulteration of authentic Aloe vera material as a reason for renewed quality control, and applied an automated 1H NMR method to 41 aloe juices and powders. [P12]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each dietary-ingredient component — US cGMP rule for dietary supplements: at least one appropriate test or examination must verify the identity of any component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)); exemption only through a petition FDA grants (111.75(a)(1)(ii)). [P11]
- Hydroxyanthracene derivatives (barbaloin/aloin) in leaf-gel products — Health Canada's Aloe vera Leaf Gel monograph requires less than 10 ppm hydroxyanthracene derivatives (barbaloin/aloin) in the finished product, with daily aloin not exceeding 1 mg. [P8]
- Hydroxyanthracene derivatives calculated as aloin, in dried leaf juice (latex) preparations — The EU monograph expresses the dose of dried aloe leaf juice as 10-30 mg hydroxyanthracene derivatives calculated as aloin. [P7]
- 1H NMR profile (aloverose, glucose, malic, lactic, citric, acetic and fumaric acids, whole-leaf material, preservatives, Mg2+, Ca2+, fructose) — Published method that quantifies 13 parameters in aloe juices and powders; the authors cite adulteration of authentic material and the IARC classification of whole leaf extract. [P12]
Supply and conservation
- CITES: Species+ shows Aloe vera as not listed in the CITES Appendices ('NC'). Its listing history shows inclusion under the genus-level Appendix II listing of Aloe spp. from 1 July 1975 and an exclusion effective 16 February 1995. [P13]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- EU herbal monograph, well-established use (EMA/HMPC/625788/2015, adopted 22 November 2016): dried aloe leaf juice preparation equivalent to 10-30 mg hydroxyanthracene derivatives (calculated as aloin), once daily at night, for adolescents over 12 and adults; not to be used for more than 1 week; contraindicated under 12. [P7]
- Health Canada, Aloe vera Leaf Gel - Oral monograph (March 28, 2025), adults 18 and older: 7.5-200 mL or 7.5-200 g fresh leaf gel per day (demulcent claim); not to exceed 200 mL or 200 g fresh leaf gel per day (antioxidant claim). [P8]
- Health Canada, Aloe - Oral monograph for latex (March 28, 2025), ages 12 and older: 50-300 mg dried latex per day, or for standardized extracts 10-30 mg hydroxyanthracene derivatives (calculated as barbaloin/aloin) per day. [P9]
Pregnancy and breastfeeding
- EU monograph on dried aloe leaf juice: use during pregnancy is contraindicated because of experimental data on a genotoxic risk of several anthranoids (e.g. emodin and aloe-emodin); use during lactation is contraindicated because active metabolites such as rhein of other anthranoids pass into breast milk in small amounts. [P7]
- Health Canada Aloe - Oral (latex) monograph: do not use if pregnant or breastfeeding. [P9]
- Health Canada Aloe vera Leaf Gel monograph label statement: ask a health care practitioner before use if pregnant or breastfeeding. [P8]
- NCCIH: aloe in gel, latex or whole leaf extract form, taken by mouth, may be unsafe during pregnancy and while breastfeeding. [P1]
Sources for this profile
- NCCIH. Aloe Vera: Usefulness and Safety (last updated February 2025), 2025-02. nccih.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Aloe Vera (last updated October 2, 2026), 2026-10-02. mskcc.org
- National Toxicology Program. TR-577: Toxicology and Carcinogenesis Studies of a Nondecolorized Whole Leaf Extract of Aloe barbadensis Miller (Aloe vera) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies) (2013), 2013. ntp.niehs.nih.gov
- National Toxicology Program. TR-553: Photocarcinogenesis Study of Aloe Vera [CASRN 481-72-1 (Aloe-emodin)] in SKH-1 Mice (Simulated Solar Light and Topical Application Study) (2010), 2010. ntp.niehs.nih.gov
- IARC Monographs. List of Classifications (retrieved October 29, 2026), 2026-10-29. monographs.iarc.who.int
- NIH LiverTox (NIDDK). Aloe Vera (Last Update: May 24, 2022), 2022-05-24. ncbi.nlm.nih.gov
- European Medicines Agency, HMPC. European Union herbal monograph on Aloe barbadensis Mill. and on Aloe (various species, mainly Aloe ferox Mill. and its hybrids), folii succus siccatus (EMA/HMPC/625788/2015; adopted 22 November 2016), 2016-11-22. ema.europa.eu
- Health Canada, NNHPD. Monograph: Aloe vera Leaf Gel - Oral (dated March 28, 2025), 2025-03-28. webprod.hc-sc.gc.ca
- Health Canada, NNHPD. Monograph: Aloe - Aloe vera/Aloe ferox - Oral (dated March 28, 2025), 2025-03-28. webprod.hc-sc.gc.ca
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of October 23, 2026), 2026-10-23. ecfr.gov
- Monakhova YB, Randel G, Diehl BW. Automated control of the organic and inorganic composition of Aloe vera extracts using 1H NMR spectroscopy. J AOAC Int 2016;99(5):1213-8 (PMID 27413027), 2016-09. pubmed.ncbi.nlm.nih.gov
- CITES/UNEP-WCMC Species+. Aloe vera (L.) Burm.f., taxon concept 23064 (retrieved October 29, 2026), 2026-10-29. speciesplus.net
Sources
- NCCIH. Aloe Vera: Usefulness and Safety (last updated February 2025), 2025-02. nccih.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Aloe Vera (last updated October 2, 2026), 2026-10-02. mskcc.org
- National Toxicology Program. TR-577: Toxicology and Carcinogenesis Studies of a Nondecolorized Whole Leaf Extract of Aloe barbadensis Miller (Aloe vera) in F344/N Rats and B6C3F1 Mice (August 2013), 2013-08. ntp.niehs.nih.gov
- FDA. Status of Certain Additional OTC Drug Category II and III Active Ingredients; Final rule. Federal Register 67(90), May 9, 2002, 2002-05-09. govinfo.gov
- European Medicines Agency. Aloes folii succus siccatus: herbal medicinal product (EU monograph 10/04/2017; assessment addendum 11/04/2022), 2022-04-11. ema.europa.eu
- Wang T, et al. Aloe vera for prevention of radiation-induced dermatitis: a systematic review and cumulative analysis of randomized controlled trials. Front Pharmacol 2022;13:976698 (PMID 36249738), 2022-09-29. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · Ashwagandha · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.